Minimization of immunosuppression in kidney transplantation, Curr Opin Nephrol Hypertens, vol.16, p.535, 2007. ,
The complementary roles of deletion and regulation in transplantation tolerance, Nat Rev Immunol, vol.3, p.147, 2003. ,
Tolerance and the "Holy Grail" of transplantation, J Surg Res, vol.111, p.109, 2003. ,
Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance, Am J Kidney Dis, vol.47, p.37, 2006. ,
Minimization of immunosuppression in adult liver transplantation: new strategies and tools, Curr Opin Organ Transplant, vol.15, p.685, 2010. ,
Immunosuppression: evolution in practice and trends, Am J Transplant, vol.5, p.874, 1993. ,
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial, Am J Transplant, vol.5, p.87, 2005. ,
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era, Am J Transplant, vol.4, p.378, 2004. ,
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors, Am J Transplant, vol.14, p.1142, 2014. ,
Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation, Transplantation, vol.76, p.1699, 2003. ,
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients, N Engl J Med, vol.347, p.488, 2002. ,
The concept of "partial" clinical tolerance, Transpl Immunol, vol.13, p.101, 2004. ,
Less is more: maintenance minimization as a step toward tolerance, Am J Transplant, vol.3, p.643, 2003. ,
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation, Am J Transplant, vol.9, p.1876, 2009. ,
Looking into the crystal ball: kidney transplantation in 2025, Nat Clin Pract Nephrol, vol.5, p.117, 2009. ,
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients, Lancet, vol.351, p.1701, 1998. ,
Prope tolerance-the future of organ transplantation from the laboratory to the clinic, Int Immunopharmacol, vol.5, p.163, 2005. ,
The beginning of clinical tolerance in solid organ allografts, Exp Clin Transplant, vol.2, p.153, 2004. ,
Immunosuppression minimization: current and future trends in transplant immunosuppression, J Am Soc Nephrol, vol.14, 1940. ,
Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen, Transplant Proc, vol.33, p.11, 2001. ,
Immunosuppressive medications for renal transplantation: a multiple choice question, Kidney Int, vol.59, p.388, 2001. ,
Results of the doubleblind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation, Transplantation, vol.66, p.29, 1998. ,
The role of newer monoclonal antibodies in renal transplantation, Transplant Proc, vol.33, p.1000, 2001. ,
What's in the pipeline? New immunosuppressive drugs in transplantation, Am J Transplant, vol.2, p.898, 2002. ,
Recent advances in immunosuppressive therapy for prevention of renal allograft rejection, Curr Opin Organ Transplant, vol.16, p.390, 2011. ,
Modulating T-cell costimulation as new immunosuppressive concept in organ transplantation, Curr Opin Organ Transplant, vol.17, p.368, 2012. ,
Memory T-cell-specific therapeutics in organ transplantation, Curr Opin Organ Transplant, vol.14, p.643, 2009. ,
Regulatory immune cells in transplantation, Nat Rev Immunol, vol.12, p.417, 2012. ,
New immunosuppressants in pediatric solid organ transplantation, Curr Opin Organ Transplant, vol.17, p.503, 2012. ,
Novel strategies in immunosuppression: issues in perspective, Transplantation, vol.91, p.1057, 2011. ,
Actively acquired tolerance of foreign cells, Nature, vol.172, p.603, 1953. ,
Is clinical tolerance realistic in the next decade?, Transpl Int, vol.19, p.539, 2006. ,
Tolerance induction in clinical transplantation, Transpl Immunol, vol.13, p.117, 2004. ,
Frontiers in nephrology: immune tolerance to allografts in humans, J Am Soc Nephrol, vol.18, p.2242, 2007. ,
Tolerogenic therapies in transplantation, Front Immunol, vol.3, 0198. ,
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody, Transplantation, vol.32, p.535, 1981. ,
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, pp.17-27, 2010. ,
Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups, Transplant Proc, vol.30, p.2155, 1998. ,
Costimulation blockade with belatacept in renal transplantation, N Engl J Med, vol.353, p.770, 2005. ,
HLA-mismatched renal transplantation without maintenance immunosuppression, N Engl J Med, vol.358, p.353, 2008. ,
Tolerance and chimerism after renal and hematopoietic-cell transplantation, N Engl J Med, vol.358, p.362, 2008. ,
Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen, J Exp Med, vol.169, p.493, 1989. ,
Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient, Transplantation, vol.59, p.1147, 1995. ,
Transplantation tolerance: lessons from experimental rodent models, Transpl Int, vol.20, p.828, 2007. ,
Transplant tolerance: models, concepts and facts, J Mol Med (Berl), vol.84, p.295, 2006. ,
Strategies for tolerance induction in nonhuman primates, Curr Opin Immunol, vol.10, p.513, 1998. ,
Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism, Curr Opin Organ Transplant, vol.16, p.366, 2011. ,
Tolerance: is it worth the risk?, Transplantation, vol.79, p.1157, 2005. ,
Challenges to achieving clinical transplantation tolerance, J Clin Invest, vol.108, p.943, 2001. ,
Ethics in the quest for transplant tolerance, Transplantation, vol.77, p.947, 2004. ,
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System, Transplantation, vol.66, p.1651, 1998. ,
In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance, Am J Transplant, vol.1, p.6, 2001. ,
Mixed chimerism and immunosuppressive drug withdrawal after HLAmismatched kidney and hematopoietic progenitor transplantation, Transplantation, vol.73, p.1386, 2002. ,
Biomarkers of overimmunosuppression, Clin Pharmacol Ther, vol.90, p.316, 2011. ,
Clinical update: immunosuppression minimisation, Lancet, vol.369, p.1676, 2007. ,
DOI : 10.1016/s0140-6736(07)60762-4
Can immune monitoring help to minimize immunosuppression in kidney transplantation?, Transpl Int, vol.22, p.110, 2009. ,
Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management, Pediatr Transplant, vol.10, p.879, 2006. ,
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics, Pharmgenomics Pers Med, vol.5, p.63, 2012. ,
Clinical trials of transplant tolerance: slow but steady progress, Am J Transplant, vol.3, p.794, 2003. ,
Translating Tolerogenic Therapies to the Clinic -Where Do We Stand and What are the Barriers?, Front Immunol, vol.3, p.317, 2012. ,
Translating tolerogenic therapies to the clinic -where do we stand?, Front Immunol, vol.3, p.254, 2012. ,
Heterologous immunity provides a potent barrier to transplantation tolerance, J Clin Invest, vol.111, p.1887, 2003. ,
Frontiers in nephrology: tolerance, J Am Soc Nephrol, vol.18, p.2240, 2007. ,
Transplantation tolerance, Pediatr Nephrol, vol.29, p.2263, 2014. ,
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs, Gastroenterology, vol.140, p.51, 2011. ,
Induced immune tolerance for kidney transplantation, N Engl J Med, vol.365, p.1359, 2011. ,
Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions?, Transpl Int, vol.26, p.576, 2013. ,
How can we measure immunologic tolerance in humans?, J Am Soc Nephrol, vol.17, p.2652, 2006. ,
Tolerance assays: measuring the unknown, Transplantation, vol.81, p.1503, 2006. ,
Towards the identification of biomarkers of transplantation tolerance, Nat Rev Immunol, vol.9, p.521, 2009. ,
Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design, Am J Transplant, vol.4, p.451, 2004. ,
09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, vol.10, p.464, 2010. ,
Defining acute renal failure: physiological principles, Intensive Care Med, vol.30, p.33, 2004. ,
A need for biomarkers of operational tolerance in liver and kidney transplantation, Am J Transplant, vol.12, p.1370, 2012. ,
Biomarkers of operational tolerance in solid organ transplantation, Expert Opin Med Diagn, vol.6, p.281, 2012. ,
Molecular diagnostics in transplantation, Nat Rev Nephrol, vol.6, p.614, 2010. ,
Biomarkers in solid organ transplantation: establishing personalized transplantation medicine, Genome Med, vol.3, p.37, 2011. ,
Can we use biomarkers and functional assays to implement personalized therapies in transplantation?, Transplantation, vol.87, p.1595, 2009. ,
Post-transplant monitoring of renal allografts: are we there yet?, Curr Opin Immunol, vol.21, p.563, 2009. ,
Immunologic monitoring in kidney transplant recipients, Kidney Res Clin Pract, vol.32, p.52, 2013. ,
Surrogate markers for the prediction of long-term outcome in transplantation: Nantes Actualite Transplantation (NAT) 2007 meeting report, Hum Immunol, vol.69, issue.2, 2008. ,
Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach, Curr Opin Organ Transplant, vol.18, p.1, 2013. ,
Clinical operational tolerance after renal transplantation: current status and future challenges, Ann Surg, vol.252, p.915, 2010. ,
Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation, Transplantation, vol.84, p.1215, 2007. ,
, Clinical transplantation tolerance. Semin Immunopathol, vol.33, p.91, 2011.
Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients, Immunol Rev, vol.258, p.208, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02163167
State of the art on the research for biomarkers allowing individual, tailormade minimization of immunosuppression, Curr Opin Organ Transplant, vol.15, p.691, 2010. ,
BANK negatively regulates Akt activation and subsequent B cell responses, Immunity, vol.24, p.259, 2006. ,
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases, Am J Transplant, vol.12, p.3296, 2012. ,
Clinical operational tolerance after kidney transplantation, Am J Transplant, vol.6, p.736, 2006. ,
Operational tolerance in kidney transplantation-improved terminology may enable more precise investigation, Transplantation, vol.96, p.36, 2013. ,
Cessation of immunosuppressive therapy after successful transplantation: a national survey, Kidney Int, vol.18, p.110, 1980. ,
Lessons of organinduced tolerance learned from historical clinical experience, Transplantation, vol.77, p.926, 2004. ,
Renal isotransplantation without immunosuppression, Ann Surg, vol.192, p.108, 1980. ,
Azathioprine: old drug, new actions, J Clin Invest, vol.111, p.1122, 2003. ,
DOI : 10.1172/jci18384
URL : http://www.jci.org/articles/view/18384/files/pdf
Prolonged survival of human-kidney homografts by immunosuppressive drug therapy, N Engl J Med, vol.268, p.1315, 1963. ,
Clinical and immunological features of very long-term survivors with a single renal transplant, Transpl Int, vol.25, p.545, 2012. ,
Decreased total CD19 (+) B lymphocytes and the occurrence of monoclonal proteins are frequent in ultra-long (30 to 44-year) renal transplant recipients: implications for allograft and patient survival, Transplant Proc, vol.45, p.1466, 2013. ,
Gene expression signature of tolerance and lymphocyte subsets in stable renal transplants: results of a cross-sectional study, Transpl Immunol, vol.31, p.11, 2014. ,
Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European multicentre trial, Lancet, vol.2, p.549, 1985. ,
Identifying specific causes of kidney allograft loss, Am J Transplant, vol.9, p.527, 2009. ,
Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study, Am J Transplant, vol.10, p.324, 2010. ,
Chronic progressive calcineurin nephrotoxicity: an overstated concept, Am J Transplant, vol.11, p.687, 2011. ,
DOI : 10.1111/j.1600-6143.2011.03505.x
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-6143.2011.03505.x
Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience, Transpl Int, vol.23, p.307, 2010. ,
DOI : 10.1111/j.1432-2277.2009.00983.x
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1432-2277.2009.00983.x
Specificity of histological markers of long-term CNI nephrotoxicity in kidneytransplant recipients under low-dose cyclosporine therapy, Am J Transplant, vol.11, p.2635, 2011. ,
The reversal of rejection in human renal homografts with subsequent development of homograft tolerance, Surg Gynecol Obstet, vol.117, p.385, 1963. ,
Transplantation tolerance from a historical perspective, Nat Rev Immunol, vol.1, p.233, 2001. ,
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967), J Am Coll Surg, vol.195, p.587, 2002. ,
Indications of immunological tolerance in kidney transplantation, Tissue Antigens, vol.51, p.637, 1998. ,
Specific immune tolerance during pregnancy after renal transplantation, Eur J Obstet Gynecol Reprod Biol, vol.70, p.217, 1996. ,
DOI : 10.1016/s0301-2115(95)02581-2
Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients, Am J Transplant, vol.12, p.640, 2012. ,
Cessation of immunosuppression after renal transplantation, Surgery, vol.79, p.278, 1976. ,
Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft, Am J Transplant, vol.6, p.2796, 2006. ,
Human allograft acceptance is associated with immune regulation, J Clin Invest, vol.106, p.145, 2000. ,
Phenotypically and functionally distinct CD8+ lymphocyte populations in longterm drug-free tolerance and chronic rejection in human kidney graft recipients, J Am Soc Nephrol, vol.17, p.294, 2006. ,
Cellular infiltrates and NFkappaB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance, Transplantation, vol.94, p.729, 2012. ,
Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis, J Cell Biochem, vol.103, p.1681, 2008. ,
Variation in numbers of CD4+ CD25 high FOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome, Transpl Int, vol.20, p.845, 2007. ,
Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients, Transplantation, vol.86, p.130, 2008. ,
Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation, Am J Transplant, vol.5, p.330, 2005. ,
Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients, Transpl Int, vol.24, p.536, 2011. ,
PARVG gene polymorphism and operational renal allograft tolerance, Transplant Proc, vol.44, p.2845, 2012. ,
Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant, J Am Soc Nephrol, vol.23, p.597, 2012. ,
Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance, Transplantation, vol.81, p.398, 2006. ,
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients, Am J Transplant, vol.11, 1916. ,
Differential monocyte STAT6 activation and CD4(+)CD25(+) Foxp3(+) T cells in kidney operational tolerance transplanted individuals, Hum Immunol, vol.71, p.442, 2010. ,
GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation, Clin Immunol, vol.142, p.117, 2012. ,
Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, p.1836, 2010. ,
Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, p.503, 2010. ,
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, p.1848, 2010. ,
Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients, J Am Soc Nephrol, vol.13, p.252, 2002. ,
Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates, J Am Soc Nephrol, vol.17, p.564, 2006. ,
Advances of genomic science and systems biology in renal transplantation: a review, Semin Immunopathol, vol.33, p.211, 2011. ,
Immune profiling: molecular monitoring in renal transplantation, Front Biosci, vol.8, p.444, 2003. ,
Protein and peptide biomarkers in organ transplantation, Biomark Med, vol.6, p.259, 2012. ,
Reconsidering the biodetection of tolerance in renal transplantation, Chimerism, vol.4, p.15, 2013. ,
What can we learn from the transcriptional characterization of spontaneously tolerant transplant recipients?, Curr Opin Organ Transplant, vol.15, p.435, 2010. ,
Gene expression signature in transplantation tolerance, Clin Chim Acta, vol.413, p.1414, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02167912
A 'biomarker signature' for tolerance in transplantation, Nat Rev Nephrol, vol.6, p.606, 2010. ,
Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective, Transpl Int, vol.22, p.120, 2009. ,
Biomarkers of tolerance: hope or hype?, Trends Transplant, vol.4, p.68, 2010. ,
Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease, PLoS ONE, vol.9, p.111597, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01687052
Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice, Nat Med, vol.20, p.659, 2014. ,
Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients, J Am Soc Nephrol, vol.20, p.1113, 2009. ,
Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function, Mol Med, vol.13, p.315, 2007. ,
Messenger RNA for FOXP3 in the urine of renal-allograft recipients, N Engl J Med, vol.353, p.2342, 2005. ,
Biomarkers of tolerance: searching for the hidden phenotype, Kidney Int Suppl, p.40, 2011. ,
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance, Proc Natl Acad Sci, vol.104, p.15448, 2007. ,
Regulatory cells and cell signatures in clinical transplantation tolerance, Curr Opin Immunol, vol.23, p.655, 2011. ,
A common gene signature across multiple studies identifies biomarkers and functional regulation in tolerance to renal allograft, Kidney Int, 2015. ,
Unique B cell differentiation profile in tolerant kidney transplant patients, Am J Transplant, vol.14, p.144, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00974748
Regulatory B cells as inhibitors of immune responses and inflammation, Immunol Rev, vol.224, p.201, 2008. ,
Molecular aspects of T-and B-cell function in uremia, Kidney Int Suppl, vol.78, p.206, 2001. ,
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression, Nephrol Dial Transplant, vol.25, p.205, 2010. ,
Defects in B-cell function and metabolism in uremia: role of parathyroid hormone, Kidney Int Suppl, vol.78, p.186, 2001. ,
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans, Am J Transplant, vol.9, p.2126, 2009. ,
B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells, Am J Transplant, vol.12, p.1784, 2012. ,
Essential role for B cells in transplantation tolerance, Curr Opin Immunol, vol.23, p.685, 2011. ,
Noncompliance after kidney transplantation: a systematic review, Transplant Proc, vol.35, p.2868, 2003. ,
Preserving the B-cell compartment favors operational tolerance in human renal transplantation, Mol Med, vol.18, p.733, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01959589
Rethinking the multiple roles of B cells in organ transplantation, Curr Opin Organ Transplant, vol.18, p.13, 2013. ,
B-cell-depleting induction therapy and acute cellular rejection, N Engl J Med, vol.360, p.2683, 2009. ,
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, Am J Transplant, vol.11, p.429, 2011. ,
Rejection and regulation: a tight balance, Curr Opin Organ Transplant, vol.17, p.1, 2012. ,
Regulatory B cells in autoimmunity: developments and controversies, Nat Rev Rheumatol, vol.6, p.636, 2010. ,
B cells in clinical transplantation tolerance, Semin Immunol, vol.24, p.92, 2012. ,
Regulatory B cells and tolerance in transplantation: from animal models to human, Front Immunol, vol.4, p.497, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02165775
B cells with immune-regulating function in transplantation, Nat Rev Nephrol, vol.10, p.389, 2014. ,
The yin and yang of B cells in graft rejection and tolerance, Transplant Rev (Orlando), vol.24, p.67, 2010. ,
A case for regulatory B cells, J Immunol, vol.176, p.705, 2006. ,
Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity, Immunol Rev, vol.233, p.146, 2010. ,
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, p.639, 2008. ,
The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, vol.182, p.7459, 2009. ,
Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway, Oncoimmunology, vol.1, p.1368, 2012. ,
Tolerant kidney transplant patients display B cells with a CD5+CD27+CD138+ phenotype that express Granzyme B and show regulatory properties, J Am Soc Nephrol, 2015. ,
Human peripheral blood B-cell compartments: a crossroad in B-cell traffic, Cytometry B Clin Cytom, vol.78, issue.1, p.47, 2010. ,
B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection, Kidney Int, vol.85, p.590, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00955526
Immunologic human renal allograft injury associates with an altered IL-10/TNF-alpha expression ratio in regulatory B cells, J Am Soc Nephrol, vol.25, p.1575, 2014. ,
Central role of CD45RA À Foxp3 hi memory Tregs in clinical kidney transplantation tolerance, J Am Soc Nephrol, 2015. ,
Management of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients -BCSH and BTS Guidelines, Br J Haematol, vol.149, p.693, 2010. ,
Role of B lymphocytes in cellmediated immunity. I. Requirement for T cells or T-cell products for antigen-induced B-cell activation, J Exp Med, vol.144, p.1175, 1976. ,
Elaboration of gene expression-based clinical decision aids for kidney transplantation: where do we stand?, Transplantation, vol.91, p.691, 2011. ,
Immunosuppression withdrawal after liver transplantation: what are the next steps?, Transplantation, vol.91, p.697, 2011. ,
Operational tolerance after liver transplantation, J Hepatol, vol.50, p.1247, 2009. ,
The liver: a special case in transplantation tolerance, Semin Liver Dis, vol.27, p.194, 2007. ,
Cellular and molecular mechanisms of liver tolerance, Immunol Rev, vol.213, p.101, 2006. ,
Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection, Transplantation, vol.85, p.1339, 2008. ,
Real-time monitoring of acute liver-allograft rejection using the Banff schema, Transplantation, vol.74, p.1290, 2002. ,
Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome, Hepatology, vol.28, p.638, 1998. ,
Weaning of immunosuppression in liver transplant recipients, Transplantation, vol.63, p.243, 1997. ,
Weaning of immunosuppression in long-term liver transplant recipients, Transplantation, vol.59, p.212, 1995. ,
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection, Semin Liver Dis, vol.12, p.51, 1992. ,
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel, Hepatology, vol.31, p.792, 2000. ,
Hot-topic debate on tolerance: immunosuppression withdrawal, Liver Transpl, vol.17, issue.3, p.69, 2011. ,
B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients, Transplantation, vol.95, p.148, 2013. ,
Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice, Autoimmunity, vol.42, p.537, 2009. ,
The role of B cells in solid organ transplantation, Semin Immunol, vol.24, p.96, 2012. ,
Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins, J Immunol, vol.176, p.640, 2006. ,
Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy, Crit Rev Oncol Hematol, vol.56, p.23, 2005. ,
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes, J Clin Invest, vol.111, p.1133, 2003. ,
The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine, Ann N Y Acad Sci, vol.685, p.400, 1993. ,
Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker, Immunotherapy, vol.2, p.625, 2010. ,
A more selective costimulatory blockade of the CD28-B7 pathway, Transpl Int, vol.24, issue.2, 2011. ,
Belatacept and Tregs: friends or foes?, Immunotherapy, vol.4, p.351, 2012. ,
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study, J Am Soc Nephrol, vol.16, p.2234, 2005. ,
Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, vol.357, p.2562, 2007. ,
Calcineurin inhibitor reduction based on maintenance immunosuppression with mycophenolate mofetil in renal transplant patients: POP study, Transplant Proc, vol.39, p.2187, 2007. ,
Strategies for Blymphocyte repertoire remodeling in transplantation tolerance, Immunol Res, vol.51, issue.1, 2011. ,
Making a B-line for transplantation tolerance, Am J Transplant, vol.11, p.420, 2011. ,
What does the future hold for cell-based tolerogenic therapy?, Nat Rev Immunol, vol.7, p.650, 2007. ,
B lymphocytedirected immunotherapy promotes long-term islet allograft survival in nonhuman primates, Nat Med, vol.13, p.1295, 2007. ,
Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients, Transplantation, vol.87, p.1394, 2009. ,
Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys, J Clin Invest, vol.120, p.1275, 2010. ,
Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20-and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody, Xenotransplantation, vol.8, p.157, 2001. ,
Limitations of rituximab/IVIg desensitization protocol in kidney transplantation, Ann Transplant, vol.16, p.19, 2011. ,
Rituximab in highly sensitized kidney transplant recipients, Transplant Proc, vol.40, p.2218, 2008. ,
The effect of desensitization protocols on human splenic B-cell populations in vivo, Am J Transplant, vol.7, p.402, 2007. ,
Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes, J Immunol, vol.186, p.614, 2011. ,
Primary B cell repertoire remodeling to achieve humoral transplantation tolerance, Semin Immunol, vol.24, p.109, 2012. ,
Donor-specific Bcell tolerance after ABO-incompatible infant heart transplantation, Nat Med, vol.10, p.1227, 2004. ,
BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection, Transplantation, vol.88, p.1229, 2009. ,
B-cell tolerance in transplantation: is repertoire remodeling the answer?, Expert Rev Clin Immunol, vol.5, p.703, 2009. ,